A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes
Clinical trial NCT06698575 · COMPLETED
Trial details
- NCT number
- NCT06698575
- Sponsor
- Assembly Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-08
- Primary completion
- 2026-01-19
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.